Enviomycin
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | IM |
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
33103-22-9 |
| PubChem (CID) | 3032903 |
| DrugBank |
DB08993 |
| ChemSpider |
16736480 |
| UNII |
XU299C23A2 |
| KEGG |
D07897 |
| ChEMBL |
CHEMBL2146142 |
| Chemical and physical data | |
| Formula | C25H43N13O10 |
| Molar mass | 685.69 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Enviomycin (INN, also called tuberactinomycin N) is an antibiotic drug, isolated from Streptomyces griseoverticillatus var. tuberacticus.[1] It is used in the treatment of tuberculosis.[2]
References
- ↑ Jinnosuke Abe et al. Antibiotic Tuberactinomycin-N and process for production thereof. US patent 3892732
- ↑ Selvakumar, N; Kumar, V; Acharyulu, GS; Rehman, F; Paramasivan, CN; Prabhakar, R (1992). "Susceptibility of south Indian strains of Mycobacterium tuberculosis to tuberactinomycin". The Indian journal of medical research. 95: 101–4. PMID 1506058.
This article is issued from Wikipedia - version of the 11/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
